Head-to-head comparison of the prohormone proBNP 1-108 with BNP and Nt-proBNP in patients admitted to emergency department

Clinical Biochemistry

Volumn 45, Issue 3, 2012, Pages 249-252

  Gruson, Damien ^a   Ketelslegers, Jean Marie ^a   Verschuren, Franck ^a   Thys, Frédéric ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

BNP; Diagnosis; Heart failure; Nt proBNP; ProBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; DYSPNEA; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRECURSOR; PRIORITY JOURNAL; THORAX PAIN;

AGED; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT ADMISSION; PEPTIDE FRAGMENTS; ROC CURVE;

EID: 84856487431     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.12.009     Document Type: Article

References (19)

1. Dries D.L., Ky B., Wu A.H., Rame J.E., Putt M.E., Cappola T.P., et al. Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure. Circ Heart Fail 2010, 3:220-227.
2. Giuliani I., Rieunier F., Larue C., Delagneau J.F., Granier C., Pau B., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006, 52:1054-1061.
3. Goetze J.P. ProBNP-derived peptides in cardiac disease. Scand J Clin Lab Invest 2004, 64:497-510.
4. Hammerer-Lercher A., Halfinger B., Sarg B., Mair J., Puschendorf B., Griesmacher A., et al. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 2008, 54:858-865.
5. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 20(112):e154-e235.
6. Januzzi J.r., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A, Krauser D.G., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005, 95:948-954.
7. Luckenbill K.N., Christenson R.H., Jaffe A.S., Mair J, Ordonez-Llanos J, Pagani F, et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 2008, 54:619-621.
8. Macheret F., Boerrigter G., McKie P., Costello-Boerrigter L., Lahr B., Heublein D., et al. Pro-B-type natriuretic peptide(1-108) circulates in the general community plasma determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2011, 57:1386-1395.
9. Maisel A.S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., Gardetto N., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001, 141:367-374.
10. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A., et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002, 39:202-209.
11. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004, 350:647-654.
12. Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005, 91:606-612.
13. Perrier A., Roy P.M., Sanchez O., Le Gal G., Meyer G., Gourdier A.L., et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005, 352:1760-1768.
14. Schoonjans F., Zalata A., Depuydt C.E., Comhaire F.H. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995, 48:257-262.
15. Seferian K.R., Tamm N.N., Semenov A.G., Mukharyamova K.S., Tolstaya A.A., Koshkina E.V., et al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007, 53:866-873.
16. Tamm N.N., Seferian K.R., Semenov A.G., Mukharyamova K.S., Koshkina E.V., Krasnoselsky M.I., Postnikov A.B., et al. Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood. Clin Chem 2008, 54:1511-1518.
17. Waldo S.W., Beede J., Isakson S., Villard-Saussine S., Fareh J., Clopton P., et al. Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 2008, 51:1874-1882.
18. Wang C.S., FitzGerald J.M., Schulzer M., Mak E., Ayas N.T. Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA 2005, 19(294):1944-1956.
19. Wu A.H., Smith A., Rame E., Wians F., Minard F., Giuliani I., et al. Analytical assay characterization for 1-108 pro-B-type natriuretic peptide on the BioPlex 2200 analyzer. Clin Chim Acta 2009, 408:143-144.